Sam is a trader and one of our lead stock analysts at AskTraders. After starting his career predominantly in the forex markets, Sam now focuses on gold and stocks with a preference for macroeconomic analysis.
Pharmaceutical firm PLx Pharma (NASDAQ: PLXP) shares are rallying premarket after the company announced on Monday evening that three stock-keeping units (SKUs) of VAZALORE will be available in over 4,500 Walmart stores across the United States in mid-August.
VAZALORE is the first and only US Food and Drug Administration (FDA) approved liquid-filled aspirin capsules.
The three SKUs available will be VAZALORE 81 mg, 12 count; VAZALORE 81 mg, 30 count; and VAZALORE 325 mg, 30 count.
“We are so excited that Walmart has committed to “Coming Soon” shelf placeholders for the next few weeks in anticipation of the stocking of all three SKUs of VAZALORE. With Walmart’s broad reach and millions of customers, patients will have easy access to VAZALORE in most of their stores nationwide,” stated Natasha Giordano, CEO of PLx.
“Walmart’s commitment is a real tribute to their recognition of VAZALORE as an innovative aspirin therapy.”
PLx Pharma's share price is currently up 21.32% at $15.08 following the announcement. Its shares have gained over 125% for the year to date.
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .